(Q33597786)

28 July 2017

1 reference

title

Venous thrombosis: a multicausal disease (English)

1 reference

28 July 2017

0 references

F R Rosendaal

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

353

1 reference

28 July 2017

issue

9159

1 reference

28 July 2017

page(s)

1167-1173

1 reference

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

The natural history and epidemiology of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Deficiency of protein C in congenital thrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Venous thromboembolic disease and ABO blood type. A cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Prevalence of antithrombin deficiency in the healthy population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Absence of thrombosis in subjects with heterozygous protein C deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

World distribution of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Homozygous protein S deficiency in an infant with purpura fulminans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Inherited predisposition to thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

A new theory on cancer-inducing mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Biological Models and Statistical Interactions: an Example from Multistage Carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910266-0

7 January 2021

10.1016/S0140-6736(98)10266-0

Identifiers

DOI

1 reference

28 July 2017

1 reference